Cross-sectional study examines whether proposed myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD) diagnostic criteria can exclude other diseases, such as MS, and rely on results of cell-based assays. ja.ma/46J4LUi ECTRIMS ACTRIMS® #MSMilan2023

Proud to have our PhD student Ana Gomes present our work on anti-MOG-IgA as a potential novel biomarker for double seronegative #CNS #demyelination. Grateful to a wonderful team of collaborators. @ectrims #MSMilan23 @ProebstelLab Departement Klinische Forschung, Universität Basel Department of Biomedicine RC2NB UniSpitalBaselCH

Proud of Patrick Lipps’ work addressing ongoing challenges in the diagnosis of MOGAD #MSMilan2023 Grateful also to be part of a scientific collaboration of ECTRIMS Departement Klinische Forschung, Universität Basel Anne-Katrin Pröbstel @ThINk_Basel Jens Kuhle Department of Biomedicine UniSpitalBaselCH University of Basel

Proud to have our first year resident Patrick Lipp present his recently published work JAMA Neurology on ongoing challenges in #MOGAD diagnosis at this years’s ECTRIMS #MSMilan23. Great collaboration with @ProebstelLab Jens Kuhle @ThINk_Basel Department of Biomedicine Departement Klinische Forschung, Universität Basel RC2NB